Nonstatin Therapy for Managing Residual Atherosclerotic Cardiovascular Disease Risk is organized by American College of Cardiology (ACC).

Date of Release: August 1, 2022
Term of Approval/Date of Expiration: July 31, 2025

Description:
The goal of this activity is for participants to be able to determine an evidence-based treatment plan that includes ensuring the optimization of statin and non-statin therapies to decrease ASCVD risk. This activity is part of the Modern Lipid Management: The Updated Medicine Cabinet grant project.

Learner Objectives:
Upon completion of this activity, you should be able to:
• Select appropriate patients who would benefit from the novel and emerging non-statin therapies.

Additional details will be posted as soon as information is available.